Iran Specialty Board Pathology case studies
Iran Specialty Board Pathology · Put your knowledge to work in context.
The Iran Specialty Board Pathology examination is the national summative assessment through which physicians who have completed an accredited pathology residency in Iran are evaluated for specialty certification. It is intended for residency graduates preparing to practice as specialist pathologists, and it is administered under the authority of the Iranian Ministry of Health and Medical Education through the Specialty Board Secretariat. Candidates should confirm all current administrative details - eligibility, scheduling, and scoring - with that body and with their university's education office, since these are set by official announcement rather than fixed permanently. The examination is broad and clinically oriented. The Iran Specialty Board Pathology case studies are 5 cases and about 3,113 words.
1Pancreatic Cyst FNA: Limited Material, Mucin, and a Preliminary Report
A 58-year-old woman has an incidental 2.8 cm unilocular cyst in the pancreatic head. Serum CEA is 6.1 ng/mL; she has no jaundice, weight loss, or pancreatitis history.
696 words, about 3 min2Macrocytic Pancytopenia: Marrow Blast Discordance and Clonal Mutations
A 72-year-old man has Hb 9.1 g/dL, MCV 104 fL, WBC 2.8 ×10^9/L, ANC 0.9 ×10^9/L, and platelets 88 ×10^9/L. B12, folate, TSH, and creatinine are normal; LDH is 210 U/L.
638 words, about 3 min3Autoverification Change Control and a Missed Hemoglobin Delta Check
During a CAP inspection of a 420-bed hospital laboratory that performs 2.1 million tests annually, the inspector reviews autoverification. Seventy-eight percent of chemistry results are autoverified.
619 words, about 3 min4Whole-Slide Imaging Validation: Scanner-Specific Failure and a Major Discordance
An academic pathology department plans primary digital diagnosis for all surgical H&E slides. Validation included 180 cases, three scanners, three pathologists, and a two-week washout.
589 words, about 3 min5Urine Biomarker for Bladder Cancer: Predictive Values and Spectrum Bias
A prospective single-center study evaluates a urine biomarker for bladder cancer in 1,000 patients with hematuria. Sensitivity is 88% and specificity 82% against cystoscopy plus biopsy.
571 words, about 3 min